Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

NCT00560794

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Universitätsklinikum Ulm Ulm, Baden-Wurttemberg, Germany
  • Julius-Maximilians-Universität Würzburg Würzburg, Bavaria, Germany
  • Klinikum der J.W. Goethe Universität Frankfurt am Main, Hesse, Germany
  • Universitätsklinikum Münster Münster, North Rhine-Westphalia, Germany
View Trial Details
Completed

Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma

NCT00060684

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Greater Baltimore Medical Center Baltimore, Maryland, United States
  • New Mexico Onc/Hem Consultants, Inc. Albuquerque, New Mexico, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

NCT00351975

Conditions
Accelerated Phase of Disease, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, +47 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
  • University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
  • Princess Margaret Hospital Cashmere, Canterbury, New Zealand
View Trial Details
Completed

A Safety Study in Patients With Chronic Lymphocytic Leukemia

NCT00283101

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Weill Medical College/Cornell University New York, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT

NCT00460421

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Loma Linda University Loma Linda, California, United States
  • Children´s Hospital Los Angeles, California, United States
  • Regents of University of California Los Angeles, California, United States
View Trial Details
Completed

AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia

NCT01431664

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Royal Marsden Hospital Surrey, London, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Leeds General Infirmary Leeds, United Kingdom
  • Royal Manchester Children's Hospital Manchester, United Kingdom
View Trial Details
Completed

Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML

NCT00123487

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +19 more
Locations
  • University Of Alabama At Birmingham Birmingham, Alabama, United States
  • Loma Linda University Cancer Center Loma Linda, California, United States
  • Ucla Dept. Of Medicine Los Angeles, California, United States
  • Washington Cancer Institute At Washington Hospital Center Washington D.C., District of Columbia, United States
View all 119 locations
View Trial Details

Related conditions